Cytheos Technologies is developing a new class of molecular signal processing chip that will transform the way biological information is captured and interpreted. At the core of our platform is a proprietary patterned surface architecture that organizes biochemical reactions into myriad spatially defined micro-domains; each engineered to detect, record, and present molecular interactions that drive their own readout.

The unique micro-domains operate as miniaturized information nodes, capable of interrogating signals from diverse biological targets and translating them into distinct optical outcomes. This scalable design supports extreme multiplexing while allowing the investigator to arbitrarily assign molecules of interest to features on the array. The result is a highly resolved biochemical snapshot of a sample that can be visually interpreted using standard imaging tools.

Behind the scenes, our surface chemistry and molecular design strategies allow selective capture, transformation, and relay of biological signals in a manner that is fundamentally distinct from conventional affinity arrays, enzymatic assays, or sequencing workflows. Because each signal transition is tied directly to the presence and behavior of the targeted biomolecules, detection happens in minutes and without costly secondary processing.

By embedding intelligence directly into the material interface, Cytheos is establishing a new category of molecular diagnostics where biology itself performs the analysis, and the chip simply reveals the result.